| Issue Date | Title | Author(s) |
| 2015-05-05 | The formulation of a pressurized metered dose inhaler containing theophylline for inhalation | Zhu, B; Haghi, M; Goud, M; Young, PM; Traini, D |
| 2013-05-13 | Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery | Scalia, S; Haghi, M; Losi, V; Trotta, V; Young, PM; Traini, D |
| 2009-02 | Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. | Zhu, M-T; Feng, W-Y; Wang, Y; Wang, B; Wang, M; Ouyang, H; Zhao, Y-L; Chai, Z-F |
| 2015-07-03 | In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation | Trotta, V; Lee, WH; Loo, CY; Haghi, M; Young, PM; Scalia, S; Traini, D |
| 2011-09-01 | Epithelial profiling of antibiotic controlled release respiratory formulations | Ong, HX; Traini, D; Bebawy, M; Young, PM |
| 2021-08-01 | Effect of combination inhaled therapy on ventilation distribution measured by SPECT/CT imaging in uncontrolled asthma. | Rutting, S; Chapman, DG; Thamrin, C; Tang, FSM; Dame Carroll, JR; Bailey, DL; Trifunovic, M; Magnussen, JS; King, GG; Farrow, CE |
| 2018-08-25 | Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery | Silva, DM; Paleco, R; Traini, D; Sencadas, V |
| 2018-08-01 | Repurposing of statins via inhalation to treat lung inflammatory conditions | Bradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX |
| 2023 | Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD. | Faiz, A; Pavlidis, S; Kuo, C-H; Rowe, A; Hiemstra, PS; Timens, W; Berg, M; Wisman, M; Guo, Y-K; Djukanović, R; Sterk, P; Meyer, KB; Nawijn, MC; Adcock, I; Chung, KF; van den Berge, M |
| 2016-10-02 | Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation | Pozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F |
